2023

1. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

   Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

2. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

   HemaSphere, Vol. 7, Núm. 1, pp. E818